您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > ONO-0300302
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
ONO-0300302
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
ONO-0300302图片
CAS NO:856689-51-5
包装与价格:
包装价格(元)
5mg电议
10mg电议

产品介绍
ONO-0300302 是一种口服有效的 LPA1 (溶血磷脂酸受体 1) 拮抗剂,其 IC50 为0.086 μM。ONO-0300302 是一种缓慢的紧密结合抑制剂,其结合亲和力随时间增加,其 Kd 为0.34 nM (37°C, 2 h)。ONO-0300302 可用于良性前列腺增生 (BPH) 的研究。
Cas No.856689-51-5
分子式C29H35NO5
分子量477.59
溶解度DMSO : 220 mg/mL (460.65 mM; Need ultrasonic)
储存条件-20°C, protect from light
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

ONO-0300302 is an orally active and potent LPA1 (lysophosphatidic acid receptor 1) antagonist, with an IC50 of 0.086 μM. ONO-0300302 is a slow tight binding inhibitor, and its binding affinity increases with time, with Kd of 0.34 nM (37 °C, 2 h). ONO-0300302 can be used for benign prostatic hyperplasia (BPH) research[1].

ONO-0300302 shows moderate stability against rat microsomes[1].

ONO-0300302 inhibits significantly an LPA (lysophosphatidic acid receptor)-induced increase of intraurethral pressure (IUP) in rat (3 mg/kg, p.o.) and dog (1 mg/kg, p.o.) over 12 h[1].

[1]. Terakado M, et al. Discovery of a Slow Tight Binding LPA1 Antagonist (ONO-0300302) for the Treatment of Benign Prostatic Hyperplasia. ACS Med Chem Lett. 2017 Nov 20;8(12):1281-1286.